Drugs Pharma

Pill for frontotemporal dementia clears safety milestone, raises hopes for prevention

HQ Team 27 November, 2025: A new once-a-day pill designed to stop frontotemporal dementia (FTD) has cleared its first major safety test, researchers.

Read More
Health Uncategorized

EU regulators reverse course, approve Alzheimer’s drug Leqembi

HQ Team November 19, 2024: The European Medicines Agency (EMA) granted conditional approval for lecanemab, for the treatment of early Alzheimer’s disease in.

Read More
Drugs Health Medical Pharma

Japan’s Eisai seeks marketing nod for Alzheimer’s drug in South Korea

HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.

Read More